OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/10/2025
Back to search
Official data from USPTO
OPENDEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
01/10/2025
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
04/19/2023
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
01/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
CN
Examiner
SCLEIDOROVICH, JOANNA
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
HitGen Inc.
Representatives
Unitalen Attorneys At Law
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for scientific purposesother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purposes; biochemical preparations for scientific purposes; buffer solutions for use in analytical chemistry; biochemical catalysts
Class 5
Chemico-pharmaceutical preparations for the treatment of diseases caused by bacteria; drugs for medical purposespharmaceutical preparations for treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparations for medical purposes for the treatment of tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseepstein-barr (eb) viruseshormonal diseasesallergicimmune disordertorch infections and immunoglobulin diseases; antibiotics; medicines for human purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; medicines made of chinese traditional medicinal herbs; biochemical drugs for the treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systeminflammatory disordersdermatological conditionsoncological diseasesblood diseasesconnective tissue disordersophthalmic diseasesgastroenterological disorders; lotions for pharmaceutical purposes being medicated lotions for treating dermatological conditions; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancerautoimmune and inflammatory diseasesrheumatoid arthritiscardiovascular diseases and infectious diseases; allergy tablets; antibiotic tablets; vitamin tablets; effervescent vitamin tablets
Class 42
Technological research in the field of medical and healthcare; conducting technical project studies for determining the feasibility of new technologies; research and development of new products for others; scientific laboratory services; product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; chemistry consultation; chemical analysis; bacteriological research; biological research
Publications
History of USPTO decisions and trademark events.
16 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/22/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/19/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/14/2024
NPUB
NOTICE OF PUBLICATION
01/31/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2024
DOCK
ASSIGNED TO EXAMINER
01/17/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/20/2023
Continuous trademark protection
Get notified about every new filing that threatens OPENDEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.